|
|
||||||||
Laboratory of Molecular Immunology, Department of Medicine, Columbia University, New York, NY 10032
A search for genes expressed in activated T cells revealed that the
nonintegrin, 67-kDa laminin binding protein (p67 LBP) is expressed on
the surface of a subset (1015%) of activated peripheral blood T
cells. Surface p67 LBP expression is detectable by FACS using the
anti-p67 LBP mAb, MLuC5, within 6 h of T cell activation with
phorbol dibutyrate and ionomycin, peaks 1836 h postactivation, and
persists for 710 days. The subset of T cells expressing p67 LBP is
composed of mature, single-positive cells (85%
CD4+8-, 15% CD4-8+)
of memory cell phenotype (100% CD45 RO+/CD45
RA-). The p67 LBP+ T cells also express the
integrin
6 chain (CD49f), which is known to associate
with p67 LBP on tumor cells. In addition, the p67 LBP+ T
cells express the integrin ß1, which associates with
6 in the laminin-specific integrin receptor very late
activation Ag (VLA)-6 (
6ß1). Expression of
an exogenous cDNA encoding the 37-kDa LBP precursor (p37 LBPP) confers
p67 LBP surface expression on a p67 LBP-negative Jurkat T cell line
(B2.7). Expression of p67 LBP induces B2.7 transfectants to adhere to
laminin, but avid laminin binding depends on coexpression of VLA-6.
Taken together, these data indicate that p67 LBP is an
activation-induced surface structure on memory T cells that, together
with VLA-6, mediates cellular adherence to
laminin.
This article has been cited by other articles:
![]() |
D. Umeda, S. Yano, K. Yamada, and H. Tachibana Green Tea Polyphenol Epigallocatechin-3-gallate Signaling Pathway through 67-kDa Laminin Receptor J. Biol. Chem., February 8, 2008; 283(6): 3050 - 3058. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Selleri, P. Ragno, P. Ricci, V. Visconte, N. Scarpato, M. V. Carriero, B. Rotoli, G. Rossi, and N. Montuori The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization Blood, October 1, 2006; 108(7): 2476 - 2484. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bonig, K.-H. Chang, B. Nakamoto, and T. Papayannopoulou The p67 laminin receptor identifies human erythroid progenitor and precursor cells and is functionally important for their bone marrow lodgment Blood, August 15, 2006; 108(4): 1230 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wang, W. Zhang, Z. Pei, M. Block, B. Wilson, J. M. Reece, D. S. Miller, and J.-S. Hong Reactive microgliosis participates in MPP+-induced dopaminergic neurodegeneration: role of 67 kDa laminin receptor FASEB J, May 1, 2006; 20(7): 906 - 915. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Givant-Horwitz, B. Davidson, and R. Reich Laminin-Induced Signaling in Tumor Cells: The Role of the Mr 67,000 Laminin Receptor Cancer Res., May 15, 2004; 64(10): 3572 - 3579. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, J. M. Carcamo, O. Borquez-Ojeda, H. Erdjument-Bromage, P. Tempst, and D. W. Golde From the Cover: The laminin receptor modulates granulocyte-macrophage colony-stimulating factor receptor complex formation and modulates its signaling PNAS, November 25, 2003; 100(24): 14000 - 14005. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rosbottom, C. L. Scudamore, H. von der Mark, E. M. Thornton, S. H. Wright, and H. R. P. Miller TGF-{beta}1 Regulates Adhesion of Mucosal Mast Cell Homologues to Laminin-1 Through Expression of Integrin {alpha}7 J. Immunol., November 15, 2002; 169(10): 5689 - 5695. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yao, S. E. Pike, and G. Tosato Laminin binding to the calreticulin fragment vasostatin regulates endothelial cell function J. Leukoc. Biol., January 1, 2002; 71(1): 47 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sixt, R. Hallmann, O. Wendler, K. Scharffetter-Kochanek, and L. M. Sorokin Cell Adhesion and Migration Properties of beta 2-Integrin Negative Polymorphonuclear Granulocytes on Defined Extracellular Matrix Molecules. RELEVANCE FOR LEUKOCYTE EXTRAVASATION J. Biol. Chem., May 25, 2001; 276(22): 18878 - 18887. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |